May Daher

6.3k total citations
38 papers, 1.0k citations indexed

About

May Daher is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, May Daher has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Immunology and 13 papers in Hematology. Recurrent topics in May Daher's work include Immune Cell Function and Interaction (20 papers), CAR-T cell therapy research (16 papers) and Acute Myeloid Leukemia Research (6 papers). May Daher is often cited by papers focused on Immune Cell Function and Interaction (20 papers), CAR-T cell therapy research (16 papers) and Acute Myeloid Leukemia Research (6 papers). May Daher collaborates with scholars based in United States, Israel and Germany. May Daher's co-authors include Katayoun Rezvani, Rafet Başar, Hind Rafei, Luciana Melo Garcia, Ye Li, Rohtesh S. Mehta, Nils G. Walter, Li Li, Elizabeth J. Shpall and Ken Chen and has published in prestigious journals such as Cell, Nucleic Acids Research and Nature Communications.

In The Last Decade

May Daher

35 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May Daher United States 16 631 629 275 126 102 38 1.0k
Jan Martínek United States 7 397 0.6× 492 0.8× 244 0.9× 84 0.7× 117 1.1× 14 924
Srinivas S. Somanchi United States 15 880 1.4× 1.1k 1.8× 224 0.8× 195 1.5× 102 1.0× 30 1.3k
Laura E. Bendzick United States 15 973 1.5× 1.1k 1.8× 435 1.6× 110 0.9× 108 1.1× 27 1.5k
Mobin Karimi United States 11 414 0.7× 524 0.8× 291 1.1× 198 1.6× 71 0.7× 32 927
Imran G. House Australia 12 700 1.1× 642 1.0× 306 1.1× 54 0.4× 117 1.1× 14 1.1k
Stephan Kloeß Germany 16 879 1.4× 931 1.5× 153 0.6× 196 1.6× 127 1.2× 24 1.2k
Caroline Arber United States 16 504 0.8× 343 0.5× 235 0.9× 116 0.9× 164 1.6× 30 762
Namiko Okuyama Japan 6 747 1.2× 467 0.7× 285 1.0× 215 1.7× 163 1.6× 9 945
Dmitry Pankov United States 11 464 0.7× 344 0.5× 183 0.7× 59 0.5× 73 0.7× 17 620
Anthony F. Daniyan United States 12 784 1.2× 363 0.6× 326 1.2× 139 1.1× 237 2.3× 24 1.0k

Countries citing papers authored by May Daher

Since Specialization
Citations

This map shows the geographic impact of May Daher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Daher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Daher more than expected).

Fields of papers citing papers by May Daher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May Daher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Daher. The network helps show where May Daher may publish in the future.

Co-authorship network of co-authors of May Daher

This figure shows the co-authorship network connecting the top 25 collaborators of May Daher. A scholar is included among the top collaborators of May Daher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May Daher. May Daher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daher, May & Katayoun Rezvani. (2025). iPSC-derived CAR-NK cells: Off-the-shelf cellular therapy for systemic sclerosis. Cell. 188(16). 4173–4174.
2.
Pasvolsky, Oren, Rima M. Saliba, Sairah Ahmed, et al.. (2024). Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 24(11). e819–e826. 2 indexed citations
3.
Khawaja, Fareed, Terri Lynn Shigle, Gabriela Rondón, et al.. (2024). Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience. Clinical Microbiology and Infection. 30(6). 803–809. 8 indexed citations
4.
Al‐Juhaishi, Taha, Yingjun Wang, Denái R. Milton, et al.. (2023). Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant. Bone Marrow Transplantation. 58(9). 1000–1007. 3 indexed citations
5.
Nieto, Yago, Pinaki P. Banerjee, Indresh Kaur, et al.. (2023). Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma. Transplantation and Cellular Therapy. 30(2). 203.e1–203.e9. 3 indexed citations
6.
Lin, Paul, Pei Lin, April L. Gilbert, et al.. (2023). CD70 CAR NK Cells in the Treatment of Multiple Myeloma. Blood. 142(Supplement 1). 3463–3463. 14 indexed citations
7.
Huang, Yuefan, Vakul Mohanty, Merve Dede, et al.. (2023). Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux. Nature Communications. 14(1). 4883–4883. 51 indexed citations
8.
Rafei, Hind, Bijender Kumar, Mayra Shanley, et al.. (2023). Radiation Therapy Sensitizes Head-and-Neck Cancer Cells to Killing by Chimeric Antigen Receptor (CAR)-NK Cells Targeting CD70. International Journal of Radiation Oncology*Biology*Physics. 117(2). S167–S168. 1 indexed citations
9.
Biederstädt, Alexander, et al.. (2022). Multiplexed engineering and precision gene editing in cellular immunotherapy. Frontiers in Immunology. 13. 1063303–1063303. 11 indexed citations
10.
Dou, Jinzhuang, Shaoheng Liang, Vakul Mohanty, et al.. (2022). Bi-order multimodal integration of single-cell data. Genome biology. 23(1). 112–112. 31 indexed citations
11.
Pasvolsky, Oren, May Daher, Gheath Alatrash, et al.. (2022). CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia. Frontiers in Oncology. 11. 800110–800110. 9 indexed citations
12.
Başar, Rafet, May Daher, & Katayoun Rezvani. (2020). Next-generation cell therapies: the emerging role of CAR-NK cells. Blood Advances. 4(22). 5868–5876. 101 indexed citations
14.
Daher, May & Katayoun Rezvani. (2018). Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering. Current Opinion in Immunology. 51. 146–153. 165 indexed citations
15.
Mehta, Rohtesh S., et al.. (2018). NK cell therapy for hematologic malignancies. International Journal of Hematology. 107(3). 262–270. 59 indexed citations
16.
Cao, Kai, David Marín, Gabriela Rondón, et al.. (2018). Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation. Frontiers in Immunology. 9. 2444–2444. 16 indexed citations
17.
Daher, May, Rafet Başar, Hila Shaim, et al.. (2017). The TGF-β/SMAD Signaling Pathway As a Mediator of NK Cell Dysfunction and Immune Evasion in Myelodysplastic Syndrome. Blood. 130. 53–53. 17 indexed citations
18.
Daher, May, Anthony M. Mustoe, Alex Morriss-Andrews, Charles L. Brooks, & Nils G. Walter. (2017). Tuning RNA folding and function through rational design of junction topology. Nucleic Acids Research. 45(16). 9706–9715. 8 indexed citations
19.
Daher, May, et al.. (2017). Soft Interactions with Model Crowders and Non-canonical Interactions with Cellular Proteins Stabilize RNA Folding. Journal of Molecular Biology. 430(4). 509–523. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026